Evinacumab: Anti-ANGPTL3 (angiopoietin-like protein 3) monoclonal antibody Treatment of homozygous familial hypercholesterolemia Treatment of dyslipidemia and cardiovascular disease

B. A. Warden, P. B. Duell

Research output: Contribution to journal › Article › peer-review

1 Scopus citations

Fingerprint

Dive into the research topics of 'Evinacumab: Anti-ANGPTL3 (angiopoietin-like protein 3) monoclonal antibody Treatment of homozygous familial hypercholesterolemia Treatment of dyslipidemia and cardiovascular disease'. Together they form a unique fingerprint.

Medicine & Life Sciences